BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Interview

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) is an immuno-oncology focused biotechnology company developing a targeted and safe approach to the management of cancer. Immunotherapy has come to the forefront in the fight against cancer, harnessing the body’s own immune system in recognizing and selectively destroying cancer cells while sparing normal ones. Immunotherapy, in addition to generally being more targeted and less toxic than commonly used types of chemotherapy, is also thought to be a potent approach with the potential to prevent cancer recurrence.